학술논문
Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.
Document Type
Journal Article
Author
Source
Subject
*HEMATURIA
*NEPHROTOXICOLOGY
*THROMBOCYTOPENIA
*HANTAVIRUS diseases
*LEUCOCYTES
*COMPARATIVE studies
*HEMORRHAGIC fever with renal syndrome
*HOSPITAL care
*RESEARCH methodology
*MEDICAL cooperation
*PROGNOSIS
*RESEARCH
*COMORBIDITY
*SYMPTOMS
*EVALUATION research
*RETROSPECTIVE studies
*SEVERITY of illness index
*RECEIVER operating characteristic curves
*ROUTINE diagnostic tests
*ODDS ratio
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1080-6040
Abstract
We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000-2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We found the following factors predictive of severe NE: nephrotoxic drug exposure (p = 0.005, point value 10); visual disorders (p = 0.02, point value 8); microscopic or macroscopic hematuria (p = 0.04, point value 7); leukocyte count >10 × 109 cells/L (p = 0.01, point value 9); and thrombocytopenia <90 × 109/L (p = 0.003, point value 11). When point values for each factor were summed, we found a score of <10 identified low-risk patients (3.3% had severe disease), and a score >20 identified high-risk patients (45.3% had severe disease). If validated in future studies, this test could be used to stratify patients by severity in research studies and in clinical practice. [ABSTRACT FROM AUTHOR]